[PDF][PDF] Superiority of CyBorD Over VAD is More Evident in First than in Second Line Treatment of Multiple Myeloma
MM El Gammal, MA Samra, NH Ibrahim… - Ann Blood Cancer … - researchgate.net
… with Dexamethasone, or Betamethasone (CyBet), replaced VAD as the standard induction
… with results of the Swedish retrospective study in 2012, PFS was better with bortezomib [18]. …
… with results of the Swedish retrospective study in 2012, PFS was better with bortezomib [18]. …
Weekly Cyclophosphamide-Bortezomib-Dexamethasone Induction Performs Comparably to Twice-Weekly Dosing with Respect to Both Response Rates and Survival …
C Thirunavukarasu, N Weber, K Morris… - Acta …, 2020 - karger.com
… and once-weekly CBD regimens in patients who underwent … the limitations of our retrospective
study design, weekly CBD … injury to persons or property resulting from any ideas, methods, …
study design, weekly CBD … injury to persons or property resulting from any ideas, methods, …